We're building a better ClinicalTrials.gov. Check it out and tell us what you think!
Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

Safety Study of CAT-8015 Immunoxin in Patients With NHL With Advance Disease (NHL)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT00515892
Recruitment Status : Unknown
Verified August 2007 by Cambridge Antibody Technology.
Recruitment status was:  Recruiting
First Posted : August 14, 2007
Last Update Posted : August 14, 2007
Sponsor:
Information provided by:
Cambridge Antibody Technology